A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...

A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled "ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL ...

ACTM-838 showed durable anti-tumor efficacy in multiple murine tumor models and synergized with anti-PD1 therapy in ...

This review examines how Western dietary patterns, high in ultra-processed foods, salt, and unhealthy fats, disrupt gut ...

Investing.com -- CERo Therapeutics (NASDAQ:CERO), a T cell therapy biotech company, is open to licensing deals or a potential sale while awaiting data on its lead asset, according to Axios, citing CEO ...

Children and teenagers are more vulnerable to meningitis than adults because their immune systems are still developing, ...

A new review highlights sepsis-induced immunosuppression as a key driver of mortality, summarizing current research and ...

Seven UCSF investigators are receiving the prestigious award for their research from the National Institutes of Health.

The super adjuvant vaccine also protected against the spread of cancer to the lungs. When exposed to melanoma cells systemically, which mimics how cancer metastasizes, none of the ...

Treatment with Sanofi's frexalimab was seen in a study to safely maintain disease control over 2.5 years in adults with ...